Tracking the 2022 monkeypox outbreak with epidemiological data in real-time - 23/06/22
Doi : 10.1016/S1473-3099(22)00359-0
Moritz U G Kraemer a, b 
, Houriiyah Tegally d, David M Pigott e, Abhishek Dasgupta a, c, James Sheldon f, Eduan Wilkinson d, Marinanicole Schultheiss g, Aimee Han g, Mark Oglia g, Spencer Marks g, Joshua Kanner g, Katelynn O’Brien g, Sudheer Dandamudi g, Benjamin Rader g, Kara Sewalk g, Ana I Bento h, i, Samuel V Scarpino f, i, j, Tulio de Oliveira d, Isaac I Bogoch k, Rebecca Katz l, John S Brownstein g
, Houriiyah Tegally d, David M Pigott e, Abhishek Dasgupta a, c, James Sheldon f, Eduan Wilkinson d, Marinanicole Schultheiss g, Aimee Han g, Mark Oglia g, Spencer Marks g, Joshua Kanner g, Katelynn O’Brien g, Sudheer Dandamudi g, Benjamin Rader g, Kara Sewalk g, Ana I Bento h, i, Samuel V Scarpino f, i, j, Tulio de Oliveira d, Isaac I Bogoch k, Rebecca Katz l, John S Brownstein g a Department of Biology, University of Oxford, Oxford OX1 3SY, UK
b Pandemic Sciences Institute, University of Oxford, Oxford OX1 3SY, UK
c Department of Computer Science, University of Oxford, Oxford OX1 3SY, UK
d Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
e Institute for Health Metrics and Evaluation, University of Washington, DC, USA
f The Roux Institute, Northeastern University, Portland, ME, USA
g Boston Children’s Hospital, Harvard Medical School, Boston, MA 02215, USA
h School of Public Health, Indiana University, Bloomington, IN, USA
i Pandemic Prevention Institute, The Rockefeller Foundation, New York, NY, USA
j Santa Fe Institute, Santa Fe, NM, USA
k Department of Medicine, University of Toronto, Toronto, ON, Canada
l Georgetown University, Washington, DC, USA
Le texte complet de cet article est disponible en PDF.
© 2022
Elsevier Ltd. Tous droits réservés.
Vol 22 - N° 7
P. 941-942 - juillet 2022 Retour au numéro
Article précédent
- Relapse in chronic pulmonary aspergillosis: more than what meets the eye? – Authors’ reply
- Inderpaul S Sehgal, Ritesh Agarwal
- Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
- Daichi Yamasoba, Yusuke Kosugi, Izumi Kimura, Shigeru Fujita, Keiya Uriu, Jumpei Ito, Kei Sato, Genotype to Phenotype Japan (G2P-Japan) Consortium
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?